ARTICLE | Clinical News
Ovidrel choriogonadotropin alfa regulatory update
October 9, 2000 7:00 AM UTC
The FDA granted marketing approval for Ovidrel, a recombinant human chorionic gonadotropin, to treat infertility by subcutaneous injection. Ovidrel also is under review in Europe. ...